Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
34 hedge funds and large institutions have $180M invested in Amryt Pharma plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
17% more funds holding
Funds holding: 29 → 34 (+5)
14% less capital invested
Capital invested by funds: $209M → $180M (-$29M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$4.22M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.4M |
| 3 |
GFI
Global Frontier Investments
Charleston,
South Carolina
|
+$2.36M |
| 4 |
AC
Armistice Capital
New York
|
+$1.69M |
| 5 |
HVC
Healthcare Value Capital
Woodcliff Lake,
New Jersey
|
+$552K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
-$4.21M |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$3.7M |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.79M |
| 4 |
NAM
Nexpoint Asset Management
Dallas,
Texas
|
-$496K |
| 5 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
-$176K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $1K | +$943 | +76 | New |
|
|
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $49 | – | – | – |
|
|
WA
28
Whitebox Advisors
Minneapolis,
Minnesota
| – | -$3.7M | -265,346 | Closed |
|
|
MIM
29
Monashee Investment Management
Boston,
Massachusetts
| – | -$2.79M | -200,000 | Closed |
|
30
Acadian Asset Management
Boston,
Massachusetts
| – | -$7K | -519 | Closed |
|
|
AIM
31
Axiom Investment Management
New York
| – | -$4K | -277 | Closed |
|
32
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$2K | -114 | Closed |
|
|
LWANC
33
Laurel Wealth Advisors (North Carolina)
Charlotte,
North Carolina
| – | +$50 | +4 | New |
|
|
EVM
34
Eaton Vance Management
Boston,
Massachusetts
| – | +$87 | +7 | New |
|
35
US Bancorp
Minneapolis,
Minnesota
| – | +$273 | +22 | New |
|
AMYT Hedge Fund Activity: Q2 2021 in Review
34 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q2 2021, worth a combined $180M — down 14% from $209M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new AMYT positions and 6 closed out — a net gain of 5 holders — while 9 added to existing stakes and 4 trimmed.
The largest buyer was Aquilo Capital Management, adding an estimated $4.22M. The largest seller was Highbridge Capital Management, cutting an estimated $4.21M.
- 34 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q2 2021, up from 29 in Q1 2021.
- Funds reported $180M of Amryt Pharma plc American Depositary Shares stock for Q2 2021, down 14% quarter-over-quarter.
- 11 funds opened new Amryt Pharma plc American Depositary Shares positions in Q2 2021 and 6 closed out, a net change of +5 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q2 2021 was Aquilo Capital Management, an estimated $4.22M added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q2 2021 was Highbridge Capital Management, an estimated $4.21M sold.
Based on aggregated 13F filings for Q2 2021.